APA (7th ed.) Citation

Malka, D., Laramée, P., Toumi, M., Trouiller, J., Macabeo, B., Poll, A., . . . Samalin, E. Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: A cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Malka, David, et al. Economic Evaluation of Encorafenib with Cetuximab in Patients with BRAF V600E-mutant Metastatic Colorectal Cancer in France: A Cost-effectiveness Analysis Using Data from the BEACON CRC Randomised Controlled Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Malka, David, et al. Economic Evaluation of Encorafenib with Cetuximab in Patients with BRAF V600E-mutant Metastatic Colorectal Cancer in France: A Cost-effectiveness Analysis Using Data from the BEACON CRC Randomised Controlled Trial. BMJ Publishing Group.